Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma, New England Journal of Medicine, vol.352, issue.10, pp.987-996, 2005. ,
DOI : 10.1056/NEJMoa043330
Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial, The Lancet Oncology, vol.10, issue.5, pp.459-466, 2009. ,
DOI : 10.1016/S1470-2045(09)70025-7
Failure pattern following complete resection plus radiotherapy and temozolomide is at the resection margin in patients with glioblastoma, Journal of Neuro-Oncology, vol.88, issue.1, pp.19-23, 2013. ,
DOI : 10.1007/s11060-012-0983-4
Residual tumor cells are unique cellular targets in glioblastoma, Annals of Neurology, vol.68, pp.264-269, 2010. ,
DOI : 10.1002/ana.22036
Fluorescence-guided surgical sampling of glioblastoma identifies phenotypically distinct tumour-initiating cell populations in the tumour mass and margin, British Journal of Cancer, vol.55, issue.3, pp.462-470, 2012. ,
DOI : 10.1038/sj.onc.1208311
Carcinoma-associated fibroblasts: Non-neoplastic tumour-promoting mesenchymal cells, Journal of Cellular Physiology, vol.68, issue.8, pp.1651-1658, 2013. ,
DOI : 10.1002/jcp.24347
Glioblastoma-associated stromal cells (GASCs) from histologically normal surgical margins have a myofibroblast phenotype and angiogenic properties, The Journal of Pathology, vol.9, issue.1, pp.74-88, 2014. ,
DOI : 10.1002/path.4332
URL : https://hal.archives-ouvertes.fr/hal-01064615
Isolation of a new cell population in the glioblastoma microenvironment, Journal of Neuro-Oncology, vol.68, issue.3, pp.493-504, 2012. ,
DOI : 10.1007/s11060-011-0701-7
URL : https://hal.archives-ouvertes.fr/inserm-00626532
A Detergent-trypsin method for the preparation of nuclei for flow cytometric DNA analysis, Cytometry, vol.2, issue.5, pp.323-327, 1983. ,
DOI : 10.1002/cyto.990030503
Human glioma cell culture: two FCS-free media could be recommended for clinical use in immunotherapy, In Vitro Cellular & Developmental Biology - Animal, vol.13, issue.9, pp.500-511, 2009. ,
DOI : 10.1007/s11626-009-9215-4
Predictive Factors for Craniopharyngioma Recurrence: A Systematic Review and Illustrative Case Report of a Rapid Recurrence, World Neurosurgery, vol.79, issue.5-6 ,
DOI : 10.1016/j.wneu.2012.07.033
Recurrence of benign meningiomas: predictive value of proliferative index, BCL2, p53, hormonal receptors and HER2 expression, British Journal of Neurosurgery, vol.46, issue.3, pp.707-720, 2011. ,
DOI : 10.1016/S0039-128X(00)00193-8
High chondroitin sulfate proteoglycan 4 expression correlates with poor outcome in patients with breast cancer, Biochemical and Biophysical Research Communications, vol.441, issue.2, pp.514-522, 2013. ,
DOI : 10.1016/j.bbrc.2013.10.093
Reduced promoter methylation and increased expression of CSPG4 negatively influences survival of HNSCC patients, International Journal of Cancer, vol.9, issue.11, 2014. ,
DOI : 10.1002/ijc.28906
Expression of the progenitor marker NG2/CSPG4 predicts poor survival and resistance to ionising radiation in glioblastoma, Acta Neuropathologica, vol.75, issue.7, pp.495-510, 2011. ,
DOI : 10.1007/s00401-011-0867-2
NG2 precursor cells in neoplasia: functional, histogenesis and therapeutic implications for malignant brain tumours, Journal of Neurocytology, vol.31, issue.6/7, pp.507-528, 2002. ,
DOI : 10.1023/A:1025795715377
Stem Cell Marker Nestin and c-Jun NH2-Terminal Kinases in Tumor and Peritumor Areas of Glioblastoma Multiforme: Possible Prognostic Implications, Clinical Cancer Research, vol.13, issue.23, pp.6970-6977, 2007. ,
DOI : 10.1158/1078-0432.CCR-07-1229
Assessment of angiogenesis by CD105 and nestin expression in peritumor tissue of glioblastoma, International Journal of Oncology, vol.38, issue.1, pp.41-50, 2011. ,
DOI : 10.3892/ijo_00000822
What is the clinical value of cancer stem cell markers in gliomas, Int J Clin Exp Pathol, vol.6, pp.334-382, 2013. ,
High expression of the stem cell marker nestin is an adverse prognostic factor in WHO grade II???III astrocytomas and oligoastrocytomas, Journal of Neuro-Oncology, vol.28, issue.1, pp.183-192, 2014. ,
DOI : 10.1007/s11060-014-1376-7
CD146, a multi-functional molecule beyond adhesion, Cancer Letters, vol.330, issue.2, pp.150-62, 2013. ,
DOI : 10.1016/j.canlet.2012.11.049
CD146 expression and its close relationship to tumor progression in systemic malignancies besides gall bladder carcinomas, Tumor Biology, vol.27, issue.1, pp.1273-1277, 2013. ,
DOI : 10.1007/s13277-012-0526-9
Targeting the NG2/CSPG4 Proteoglycan Retards Tumour Growth and Angiogenesis in Preclinical Models of GBM and Melanoma, PLoS ONE, vol.4, issue.7, pp.23062-23075, 2011. ,
DOI : 10.1371/journal.pone.0023062.s003
Nestin: A novel angiogenesis marker and possible target for tumor angiogenesis, World Journal of Gastroenterology, vol.19, issue.1, pp.42-50, 2013. ,
DOI : 10.3748/wjg.v19.i1.42
Myofibroblasts, Current Opinion in Rheumatology, vol.25, issue.1, pp.71-78, 2013. ,
DOI : 10.1097/BOR.0b013e32835b1352
Distinct epigenetic changes in the stromal cells of breast cancers, Nature Genetics, vol.93, issue.8, pp.899-905, 2005. ,
DOI : 10.1038/ng1596
Gene Promoter Methylation in Prostate Tumor-Associated Stromal Cells, JNCI Journal of the National Cancer Institute, vol.98, issue.4, pp.255-61, 2006. ,
DOI : 10.1093/jnci/djj051
Global Hypomethylation of Genomic DNA in Cancer-Associated Myofibroblasts, Cancer Research, vol.68, issue.23, pp.9900-9908, 2008. ,
DOI : 10.1158/0008-5472.CAN-08-1319
Breast cancer cells induce stromal fibroblasts to secrete ADAMTS1 for cancer invasion through an epigenetic change, PloS One, vol.7, pp.35128-35158, 2012. ,
Altered expression of chondroitin sulfate proteoglycan in the stroma of human colon carcinoma. Hypomethylation of PG-40 gene correlates with increased PG-40 content and mRNA levels, J Biol Chem, vol.265, pp.11389-96, 1990. ,
Epigenetic Regulation of Tumor Endothelial Cell Anergy: Silencing of Intercellular Adhesion Molecule-1 by Histone Modifications, Cancer Research, vol.66, issue.22, pp.10770-10777, 2006. ,
DOI : 10.1158/0008-5472.CAN-06-1609
Concurrent hypermethylation of DNMT1, MGMT and EGFR genes in progression of gliomas, Diagn Pathol, vol.7, issue.8, 2012. ,
Epigenetic inactivation of EGFR by CpG island hypermethylation in cancer, Cancer Biology & Therapy, vol.5, issue.11, pp.1494-501, 2006. ,
DOI : 10.4161/cbt.5.11.3299
Epidermal growth factor receptor (EGFR) gene promoter methylation and cetuximab treatment in colorectal cancer patients, British Journal of Cancer, vol.31, issue.11, pp.1786-90, 2011. ,
DOI : 10.1073/pnas.81.23.7308
Gene expression in extratumoral microenvironment predicts clinical outcome in breast cancer patients, Breast Cancer Research, vol.6, issue.2, pp.51-87, 2012. ,
DOI : 10.1371/journal.pone.0018196
Breast stromal fibroblasts from histologically normal surgical margins are pro-carcinogenic, The Journal of Pathology, vol.367, issue.4, pp.457-65, 2013. ,
DOI : 10.1002/path.4256
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4284036
The influence of surgery on recurrence pattern of glioblastoma, Clinical Neurology and Neurosurgery, vol.115, issue.1, pp.37-43, 2013. ,
DOI : 10.1016/j.clineuro.2012.04.005
Positron Emission Tomography-guided Volumetric Resection of Supratentorial High-grade Gliomas: A Survival Analysis in 66 Consecutive Patients, Neurosurgery, vol.64, issue.3, pp.471-81, 2009. ,
DOI : 10.1227/01.NEU.0000338949.94496.85
Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial, The Lancet Oncology, vol.7, issue.5, pp.392-401, 2006. ,
DOI : 10.1016/S1470-2045(06)70665-9
Prognostic Value of Residual Fluorescent Tissue in Glioblastoma Patients After Gross Total Resection in 5-Aminolevulinic Acid-Guided Surgery, Neurosurgery, vol.72, issue.6, pp.915-935, 2013. ,
DOI : 10.1227/NEU.0b013e31828c3974